Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.40%
#2 Pons Pons +33.09%
#3 TENDIES TENDIES +31.51%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.78%
#5 Starpower Starpower +28.97%
#6 StonkBroker StonkBroker +23.95%
#7 SkyAI SkyAI +22.66%
#8 Mubarak Mubarak +22.28%
#9 PondCoin PondCoin +21.09%
#10 Ocean Protocol Ocean Protocol +19.89%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
BioLASCO Taiwan Co., Ltd. BioLASCO Taiwan Co., Ltd.

BioLASCO Taiwan Co., Ltd.

6662
Classifica tra le azioni #28966
BioLASCO Taiwan Co., Ltd., established in Taipei in 1990, operates as an... BioLASCO Taiwan Co., Ltd., established in Taipei in 1990, operates as an international supplier of bio-materials and surgical support services. The company specializes in breeding and producing Specific Pathogen-Free (SPF) laboratory rodents, encompassing various outbreed stocks, inbreed strains, and immune-deficient models, alongside providing bespoke animal model services. Its product portfolio extends to critical diagnostic and research tools, including kits for endotoxin detection, animal health diagnostics, and serological analysis, as well as biological indicators. Furthermore, BioLASCO furnishes a comprehensive array of laboratory equipment vital for animal research and facility management. This sophisticated equipment includes Individually Ventilated Cage (IVC) systems and ventilated housing units, professional automated animal watering systems, transponders, chlorine dioxide gas generators, and specialized devices such as mouse and rat tail cuff blood pressure systems, analgesia equipment, animal behavioral systems, metabolism and behavior tracking systems. The company also offers XPERT cabinet X-ray systems, automatic cleaning equipment, laboratory workstations, isolation chambers, and foggers.
Prezzo delle azioni
$0.92217181
Ultima sincronizzazione: 2026-08-18
Capitalizzazione di mercato
$23.62M
Variazione (1 giorno)
-2.36%
Variazione (1 anno)
-14.52%
Paese
TW
Scambia BioLASCO Taiwan Co., Ltd. (6662)

Categoria

Healthcare
Utile per BioLASCO Taiwan Co., Ltd. (6662)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di BioLASCO Taiwan Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di BioLASCO Taiwan Co., Ltd. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH